Guangjun Jiao Selected Research

Osteoporosis

2/2023	Ortho-silicic Acid Plays a Protective Role in Glucocorticoid-Induced Osteoporosis via the Akt/Bad Signal Pathway In Vitro and In Vivo.
1/2023	WTAP-mediated m6A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis.
1/2023	Arginine methylation of PPP1CA by CARM1 regulates glucose metabolism and affects osteogenic differentiation and osteoclastic differentiation.
1/2023	WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.
5/2021	Bionic Tiger-Bone Powder Improves Bone Microstructure and Bone Biomechanical Strength of Ovariectomized Rats.
1/2021	Ortho-silicic acid enhances osteogenesis of osteoblasts through the upregulation of miR-130b which directly targets PTEN.
8/2019	Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway.
7/2019	LncRNA SNHG1 modulates p38 MAPK pathway through Nedd4 and thus inhibits osteogenic differentiation of bone marrow mesenchymal stem cells.
2/2018	MiR-455-3p activates Nrf2/ARE signaling via HDAC2 and protects osteoblasts from oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangjun Jiao Research Topics

Disease

9	Osteoporosis 02/2023 - 02/2018
7	Osteosarcoma (Osteogenic Sarcoma) 01/2024 - 10/2013
7	Neoplasms (Cancer) 01/2024 - 05/2015
3	Thrombosis (Thrombus) 06/2023 - 10/2020
3	Inflammation (Inflammations) 05/2021 - 05/2018
2	Wilms Tumor (Wilm's Tumor) 01/2023 - 01/2023
2	Neoplasm Metastasis (Metastasis) 05/2021 - 08/2017
1	Spondylolysis 02/2024
1	Postoperative Hemorrhage 02/2024
1	Necrosis 01/2024
1	Osteonecrosis (Kienbock's Disease) 01/2024
1	Venous Thromboembolism 10/2020
1	Pathologic Constriction (Stenosis) 10/2020
1	Spondylolisthesis 10/2020
1	Chronic Renal Insufficiency 07/2020
1	Femoral Fractures (Femoral Fracture) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Bone Diseases (Bone Disease) 08/2019
1	Neuroinflammatory Diseases 09/2018
1	Hypoxia (Hypoxemia) 09/2018
1	Osteoarthritis 05/2018
1	Chondrosarcoma 05/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2011

Drug/Important Bio-Agent (IBA)

3	Silicic AcidIBA 01/2024 - 01/2021
3	Tranexamic Acid (AMCA)FDA Link 06/2023 - 10/2020
3	RivaroxabanIBA 06/2023 - 10/2020
3	6-methyladenineIBA 01/2023 - 01/2023
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2021
2	GlucocorticoidsIBA 01/2024 - 02/2023
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2023
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 05/2021 - 08/2017
2	ResveratrolIBA 01/2020 - 05/2018
1	N-methyladenosineIBA 01/2023
1	coactivator-associated arginine methyltransferase 1IBA 01/2023
1	Ferredoxins (Ferredoxin)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	PowdersIBA 05/2021
1	fibrin fragment D (D-dimer)IBA 07/2020
1	Conditioned Culture MediaIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Trace Elements (Biometals)IBA 08/2019
1	SiliconIBA 08/2019
1	Glucose (Dextrose)FDA LinkGeneric 09/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018
1	Oxygen (Dioxygen)IBA 09/2018
1	CytokinesIBA 09/2018
1	acetylpuerarinIBA 09/2018
1	Metalloproteases (Metalloproteinases)IBA 05/2018
1	3-methyladenineIBA 05/2018
1	Matrix Metalloproteinases (MMPs)IBA 05/2018
1	CateninsIBA 05/2018
1	ferric ammonium citrate FDA Link 02/2018
1	Phosphotransferases (Kinase)IBA 08/2017
1	Transcription Factors (Transcription Factor)IBA 10/2016
1	OsteocalcinIBA 10/2016
1	AcidsIBA 10/2016
1	Collagen Type I (Type I Collagen)IBA 10/2016
1	Arsenic Trioxide (Trisenox)FDA Link 05/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	Antineoplastic Agents (Antineoplastics)IBA 05/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2013
1	Bortezomib (Velcade)FDA Link 10/2013
1	Mitogen-Activated Protein KinasesIBA 10/2013
1	ORALIT (ORS)IBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2024 - 05/2021
2	Transplantation 08/2017 - 03/2011
1	Pedicle Screws 02/2024
1	Length of Stay 02/2024
1	Operative Time 02/2024
1	Blood Transfusion (Blood Transfusions) 07/2020
1	Ovariectomy (Oophorectomy) 07/2019